Platelet Rich Plasma Versus Radio Frequency for Chronic Knee Arthritis

Osteoarthritis (OA) affects aged above 45 years. RF has been used for several painful conditions. There have been a few attempts to use RF current for the treatment of painful conditions of joints of the extremities. It was also used for the treatment of painful conditions of the hip joint.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteo Arthritis Knee Chronic Pain Neurologic Manifestations Pain Pain, Chronic Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

30 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Emad Zarief Kamel Said

Asyut, 71111, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

osteoarthritis knee

Exclusion criteria

coaguloapthy
patient refusal

Treatment and study plan

Radiofrequency

Procedure

radiofrequency of the genicular nerves

Platelet Rich Plasma injection

Procedure

intra articular injection of platelet rich plasma

Primary outcomes

pain visual analog scale

Time frame: 12 months

assessment of visual analog scale (VAS) VAS of zero means no pain, and 10 means sever pain

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Efficacy of Genicular Nerve Radiofrequency Ablation Versus Intra-Articular Platelet Rich Plasma in Chronic Knee Osteoarthritis; a Randomized Clinical Trial

Important dates

Study start: 2018
Primary completion: 2019
Study completion: 2019
First posted: Mar 22, 2019
Registry last updated: Jan 18, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed